Incidence of Adverse Events Related to Therapies with sodium iodine (131I): Contribution to the Pharmacovigilance in Brazil
Radiopharmaceuticals for therapeutic have been increasingly used for the treatment of various pathologies. Beta-emitting radionuclides stand out in this modality due to the physical characteristics of the emitted particle. Iodine-131 (131I) is an example of a beta-emitting radionuclide, applied in t...
Saved in:
| Main Authors: | Jaqueline Cardena Fernandes, Elaine Bortoleti de Araújo, Adriana Iozzi Joaquim |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Brazilian Radiation Protection Society (Sociedade Brasileira de Proteção Radiológica, SBPR)
2024-09-01
|
| Series: | Brazilian Journal of Radiation Sciences |
| Subjects: | |
| Online Access: | https://bjrs.org.br/revista/index.php/REVISTA/article/view/2481 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of biokinetics and dosimetry in [131I]-NaI therapies: whole-body images quantification versus lower limb region
by: Bianca Lemos Lima, et al.
Published: (2020-06-01) -
Evaluation of the physical and biological dosimetry methods in iodine-131-treated patients
by: Ayşegül Ozdal, et al.
Published: (2018-01-01) -
Clinical predictors of I-131 therapy failure in differentiated thyroid cancer by machine learning: A single-center experience
by: David J. Lubin, et al.
Published: (2021-07-01) -
Empiric Therapy with Low-Dose I-131 in Differentiated Cancer Thyroid: What is the Magic Number?
by: Ajit Shinto, et al.
Published: (2013-04-01) -
Low-Dose Versus Standard-Dose Radioiodine Therapy in Differentiated Thyroid Cancer: Focus on Tolerability in a Retrospective Evaluation
by: Laura Musso, et al.
Published: (2025-03-01)